ADVERTISEMENT

Saudi Arabia

Backed By Briumvi Collaboration, Neuraxpharm Makes A Base In Middle East

Backed By Briumvi Collaboration, Neuraxpharm Makes A Base In Middle East

Neuraxpharm is making further waves outside of Europe, launching operations in the Middle East just a year after entering Central and South America.

Saudi Arabia To Mandate Economic Evaluation Studies For New Drugs From July 2025

Saudi Arabia To Mandate Economic Evaluation Studies For New Drugs From July 2025

Companies marketing pharmaceutical products in Saudi Arabia are being urged to prepare for upcoming mandatory pharmacoeconomic assessments to demonstrate the added value of their drugs over existing treatments.

Global Pharma Guidance Tracker – August 2024

Global Pharma Guidance Tracker – August 2024

Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.

Global Pharma Guidance Tracker – June 2024

Global Pharma Guidance Tracker – June 2024

Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.

TVM Capital Boosts Boston Oncology Arabia’s Capacities With $35m Injection

TVM Capital Boosts Boston Oncology Arabia’s Capacities With $35m Injection

Following on from the recently announced closing of a Saudi Arabia-focused fund, TVM Capital has doubled down on its local efforts with a further $35m investment into Boston Oncology Arabia’s efforts.

Final Funding Blow For J&J’s Spravato In England, Despite Reimbursement In 26 Other Countries

Final Funding Blow For J&J’s Spravato In England, Despite Reimbursement In 26 Other Countries

J&J says it has “exhausted all current viable avenues” to get its antidepressant nasal spray Spravato reimbursed on England’s National Health Service, after NICE decided against re-appraising the drug following numerous funding rejections.

Global Pharma Guidance Tracker – May 2024

Global Pharma Guidance Tracker – May 2024

Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.

Global Medtech Guidance Tracker: May 2024

Global Medtech Guidance Tracker: May 2024

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Sixty-five documents have been posted on the tracker since its last update.

Bayer Takes Its Aspirin-Branded Digital CVD Screening Tool To Saudi Arabia

Bayer Takes Its Aspirin-Branded Digital CVD Screening Tool To Saudi Arabia

Bayer Consumer Health's recently established Precision Health unit launches its Aspirin Heart Risk Assessment tool in Saudi Arabia. Developed in partnership with British medtech firm Huma Therapeutics, Bayer is planning to roll out the digital tool to other countries in the Middle East and also Latin America. 

Global Pharma Guidance Tracker – April 2024

Global Pharma Guidance Tracker – April 2024

Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.